Talk:Dose escalation schedule
Discussion page·3 threads·no archives
This is the discussion page for the article Dose escalation schedule. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.
Selective adaptationResolved
The point that nausea attenuates while appetite suppression does not is the mechanistic core of why escalation works, and it was missing from an earlier revision. — EscalationEira (talk) 10:10, 25 January 2026 (UTC)
Restored and tied to the gastric-emptying tachyphylaxis, which is the documented half of the mechanism. ✓ Done — ToleranceTove (talk) 13:45, 25 January 2026 (UTC)
Schedule table is descriptiveDone
A table of doses and intervals is the closest this wiki comes to a dosing chart. The disclaimer immediately after is doing necessary work and must stay adjacent. — NPOV_Nadia (talk) 09:30, 19 April 2026 (UTC)
It says these are the schedules used in the pivotal trials and reflected in labelling — a factual claim about published schedules rather than a recommendation. ✓ Done — TitrationTheo (talk) 13:15, 19 April 2026 (UTC)
Tirzepatide table row
The tirzepatide row omits the 7.5 and 12.5 mg intermediate maintenance doses. Should they be listed? — TirzTaxonomist (talk) 11:20, 12 June 2026 (UTC)
They are maintenance options rather than escalation steps, which is a distinction the table would blur. I would leave the row as the escalation path. — EscalationEira (talk) 14:55, 12 June 2026 (UTC)